[Epidemiology of urogenital cancers in France].
Estimates of cancer incidence and mortality in France as well as survival data are published by the cancer registry network (Francim). In 2000, the number of new cancer cases was almost 280,000 in France. This number has been gradually increasing, partly due to population aging. The proportion of urological cancers is increasing as well, as a consequence of the marked increase in number of prostate cancers. The estimated number of new cases for the 4 main urological cancers in 2000 reached 61,174, distributed as follows: 40,310 prostate cancers, 10,771 bladder cancers, 8,293 kidney cancers and 1,800 testis cancers. Urological tumours represented at the time 22% of new cancer cases in France: 35% of male cancers (56,402 /161,025) and 4% of female cancers (4,772/117,228). The relative five-year survival for prostate cancers is high: 80%. It is below that of testis cancers (95% after 5 years), but higher than that of kidney cancers (64% in men and 63% in women after five years). Of all urological cancers, bladder cancers have the worst prognosis, since the relative five-year survival is 60% in men and especially 50% in women.
Rébillard
Xavier
X
Service d'urologie, clinique Beau-Soleil, 34070 Montpellier. x.Rebillard@languedoc.mutualite.fr
Tretarre
Brigitte
B
D005602:France / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D016019:Survival Analysis; D014565:Urogenital Neoplasms / Q000453:epidemiology*